enVVeno Medical Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Public

  • Employees
  • 33

Employees

  • Stock Symbol
  • NVNO

Stock Symbol

  • Share Price
  • $6.22
  • (As of Monday Closing)

enVVeno Medical General Information

Description

enVVeno Medical Corp is a medical device company focused on the advancement of bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The company first developed the VenoValve, which was a surgical replacement venous valve. It is focused on its next-generation, non-surgical venous valve product, called the enVVe System which consists of the enVVe Valve, enVVe Delivery System, enVVe Nose Cone, the enVVe Delivery System Accessories, and the enVVe Crimping System. The enVVe System is designed to treat severe deep chronic venous insufficiency through a minimally invasive, catheter-based approach. It operates in a single segment, Medical Device development, located in a single geographic location, the United States.

Contact Information

Website
www.envveno.com
Formerly Known As
Hancock Jaffe Laboratories
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Corporate Office
  • 70 Doppler
  • Irvine, CA 92618
  • United States
+1 (949)
Primary Industry
Therapeutic Devices
Stock Exchange
NAS
Vertical(s)
Corporate Office
  • 70 Doppler
  • Irvine, CA 92618
  • United States
+1 (949)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

enVVeno Medical Stock Performance

As of 16-Nov-2026, enVVeno Medical’s stock price is $6.22. Its current market cap is $4.13M with 695K shares.

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$6.22 $6.17 $5.80 - $14.66 $4.13M 695K 30.5K -$23.35

enVVeno Medical Financials Summary

As of 30-Sep-2026, enVVeno Medical has a trailing 12-month revenue of null.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV (15,561) (23,676) 5,728 44,229
Revenue 0 0 0 0
EBITDA (15,322) (19,675) (21,680) (23,150)
Net Income (15,552) (19,472) (21,819) (23,516)
Total Assets 19,489 29,562 44,954 48,635
Total Debt 408 700 1,064 1,402
Public Fundamental Data provided by Morningstar, Inc. disclaimer

enVVeno Medical Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore enVVeno Medical‘s full profile, request access.

Request a free trial

enVVeno Medical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
enVVeno Medical Corp is a medical device company focused on the advancement of bioprosthetic (tissue-based) solutions to
Therapeutic Devices
Irvine, CA
33 As of 2026

Santa Rosa, CA
 

South Jordan, UT
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

enVVeno Medical Competitors (21)

One of enVVeno Medical’s 21 competitors is Endologix, a Corporation company based in Santa Rosa, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Endologix Corporation Santa Rosa, CA
Merit Medical Systems Corporation South Jordan, UT
Electromed Corporation New Prague, MN
Dornier MedTech Corporation Weßling, Germany
Medtronic Corporation Minneapolis, MN
You’re viewing 5 of 21 competitors. Get the full list »

enVVeno Medical Patents

enVVeno Medical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2023220249-A1 Method of manufacturing a valve for transcatheter delivery Inactive 11-May-2022
US-20230363901-A1 Transcatheter valve for venous insufficiency Pending 11-May-2022
WO-2023220254-A1 Transcatheter valve for venous insufficiency Inactive 11-May-2022
AU-2023268468-A1 Transcatheter valve system and method for venous insufficiency Pending 11-May-2022
EP-4522079-A1 Transcatheter valve system and method for venous insufficiency Pending 11-May-2022 A61F2/2475
To view enVVeno Medical’s complete patent history, request access »

enVVeno Medical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

enVVeno Medical ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

34.52 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,592

Rank

Percentile

Healthcare

Industry

of 590

Rank

Percentile

Medical Devices

Subindustry

of 209

Rank

Percentile

To view enVVeno Medical’s complete esg history, request access »

enVVeno Medical FAQs

  • When was enVVeno Medical founded?

    enVVeno Medical was founded in 1999.

  • Where is enVVeno Medical headquartered?

    enVVeno Medical is headquartered in Irvine, CA.

  • What is the size of enVVeno Medical?

    enVVeno Medical has 33 total employees.

  • What industry is enVVeno Medical in?

    enVVeno Medical’s primary industry is Therapeutic Devices.

  • Is enVVeno Medical a private or public company?

    enVVeno Medical is a Public company.

  • What is enVVeno Medical’s stock symbol?

    The ticker symbol for enVVeno Medical is NVNO.

  • What is the current stock price of enVVeno Medical?

    As of 16-Nov-2026 the stock price of enVVeno Medical is $6.22.

  • What is the current market cap of enVVeno Medical?

    The current market capitalization of enVVeno Medical is $4.13M.

  • Who are enVVeno Medical’s competitors?

    Endologix, Merit Medical Systems, Electromed, Dornier MedTech, and Medtronic are some of the 21 competitors of enVVeno Medical.

  • What is enVVeno Medical’s annual earnings per share (EPS)?

    enVVeno Medical’s EPS for 12 months was -$23.35.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process